安徽宏宇五洲医疗器械股份有限公司2025年第一次临时股东会决议公告

Group 1 - The company held its first extraordinary general meeting of shareholders in 2025 on November 13, 2025, with a combination of on-site and online voting [3][4][6] - A total of 31 shareholders attended the meeting, representing 48,814,500 shares, which accounts for 71.7860% of the total voting shares [6] - The meeting was convened by the company's third board of directors and was deemed legal and compliant with relevant laws and regulations [5][46] Group 2 - All proposals presented at the meeting were approved without any dissenting votes [2][9] - The proposal to amend the company's articles of association received 48,806,100 votes in favor, representing 99.9828% of the valid votes cast [9][12] - The proposal to amend the governance rules and other related proposals also received similar overwhelming support, with no votes against [12][15][18] Group 3 - The legal opinions provided by Anhui Tianhe Law Firm confirmed that the meeting's convening, attendance, voting procedures, and results were in accordance with the Company Law and other relevant regulations [46] - The company has made available documents related to the meeting, including the resolutions and legal opinions for public reference [47]